Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study
Liyun Zheng(Nanchang University), Jiansong Ji(Wenzhou Medical University), Minjiang Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Weiqian Chen(First Affiliated Hospital Zhejiang University), Xulu Wu(Lishui University), Jingjing Song(Capital Medical University), Fazong Wu(Wenzhou Medical University), Zhongwei Zhao(Wenzhou Medical University), Shiji Fang(Wenzhou Medical University), Qiaoyou Weng(Wenzhou Medical University)
Cited by 90
Related Papers
The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma
|Cell Communication and Signaling|2020|232
Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival
|Scientific Reports|2016|143
CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway
|Journal of Experimental & Clinical Cancer Research|2020|107
Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study
|Journal of Hepatology|2021|101
Interactions between interleukin-6 and myeloid-derived suppressor cells drive the chemoresistant phenotype of hepatocellular cancer
|Experimental Cell Research|2017|88